WATER SOLUBLE CURCUMIN COMPOSITIONS FOR USE IN ANTI-CANCER AND ANTI-INFLAMMATORY THERAPY; Serteyn, Didier ; et alPatent (2011) The present invention relates to the medical field. In a first aspect the present invention relates to novel water soluble cyclodextrin-curcumin complexes having a pharmacological activity, in particular ... [more ▼] The present invention relates to the medical field. In a first aspect the present invention relates to novel water soluble cyclodextrin-curcumin complexes having a pharmacological activity, in particular an anti-tumour and/or anti-inflammatory activity, and improved physico-chemical properties. In a second aspect, the present invention relates to a method for preparation of said water soluble curcumin derivatives. The invention further relates in a third aspect to a pharmaceutical composition comprising an effective amount of said water soluble curcumin derivatives. In a fourth aspect, the present invention concerns the use of said water soluble cucumin derivatives as a medicament and the use of said water soluble curcumin derivatives for the preparation of a medicament for the treatment of cancer and inflammatory diseases. In a fifth aspect, the present invention relates to the use of a pharmaceutical composition comprising said water soluble curcumin derivatives in the treatment of cancer and inflammatory diseases and to a new pharmaceutical composition comprising said water soluble curcumin derivatives. [less ▲] Detailed reference viewed: 77 (7 ULg) 8-Chloro-6-(3-dimethylaminopropylamino)-11H-pyrido[2,3-b][1,4]benzodiazepineDupont, Léon ; ; et alin Acta Crystallographica Section E-Structure Reports Online (2002), 58(Part 1), 69-71 The crystal structure determination of the title compound, C17H20ClN5, has been undertaken as part of studies on antipsychotic drugs. Its structure is compared with that of clozapine (C18H19ClN4), a well ... [more ▼] The crystal structure determination of the title compound, C17H20ClN5, has been undertaken as part of studies on antipsychotic drugs. Its structure is compared with that of clozapine (C18H19ClN4), a well known atypical antipsychotic drug. The side chain is more flexible than in the N-methylpiperazine analogues, but its folding is influenced by an intramolecular N-H . . .N hydrogen bond. The distances between the N-distal atom, a possible pharmacophore, and the centres of the two aromatic rings are significantly shorter than in clozapine. The crystal packing involves one N-H . . .N intermolecular hydrogen bond. The title compound showed no affinity for the receptors tested. [less ▲] Detailed reference viewed: 25 (0 ULg) The behavioral effects of acute and chronic JL 13, a putative antipsychotic, in Cebus non-human primates; ; et al in Psychopharmacology (2001), 157 Detailed reference viewed: 2 (0 ULg) Inhibition by JL3 of some effects of histamine and of the anaphylactoid reactions induced by dextran in rats.Damas, Jacques ; Garbacki, Nancy ; et alPoster (2001) Detailed reference viewed: 4 (0 ULg) Evaluation de l'activité anti-inflammatoire sur COX-1 et COX-2 de l'actéoside et de plantes médicinales en contenant.Garbacki, Nancy ; ; Tits, Monique et alPoster (2000) Detailed reference viewed: 53 (0 ULg) Anti-inflammatory and chondroprotective activity of prodelphinidins isolated from Ribes nigrum leaves.Tits, Monique ; ; et alPoster (2000) Detailed reference viewed: 13 (0 ULg) Influence of JL3, a potential antidepressant, on rat noradrenergic and serotonergic systemsLiégeois, Jean-François ; Seutin, Vincent ; Scuvée-Moreau, Jacqueline et alin European Journal of Pharmacology (1999), 386 Detailed reference viewed: 60 (41 ULg) Study of the Influence of Both Cyclodextrins and L-Lysine on the Aqueous Solubility of Nimesulide; Isolation and Characterization of Nimesulide-L-Lysine-Cyclodextrin ComplexesPiel, Géraldine ; Pirotte, Bernard ; et alin Journal of Pharmaceutical Sciences (1997), 86(4), 475-80 Nimesulide is a nonsteroidal antiinflammatory drug that exhibits a very poor water solubility (0.01 mg.mL-1). A nimesulide-beta-cyclodextrin complex prepared according to patent application WO 94/ 02177 ... [more ▼] Nimesulide is a nonsteroidal antiinflammatory drug that exhibits a very poor water solubility (0.01 mg.mL-1). A nimesulide-beta-cyclodextrin complex prepared according to patent application WO 94/ 02177 has an aqueous solubility of approximately 16 mg.mL-1 of nimesulide. A nimesulide-L-lysine salt has also been prepared and increases the aqueous solubility of nimesulide to approximately 5.0-7.5 mg.mL-1. The purpose of the present study was to investigate the interaction of both cyclodextrins and L-lysine on the aqueous solubility of nimesulide. Nimesulide-L-lysine-beta- or gamma-cyclodextrin complexes were prepared by spray-drying. The inclusion of the nimesulide-L-lysine salt into the cyclodextrin cavity was confirmed by differential scanning calorimetry and proton nuclear magnetic resonance spectroscopy. These complexes offered remarkable aqueous solubility. The incorporation of nimesulide in a nimesulide-L-lysine-beta-cyclodextrin complex increased its water solubility by a factor of 10 at pH 1.5 (0.050 mg.mL-1 for the complex versus 0.005 mg.mL-1 for nimesulide), 160 at pH 6.8 (2.373 mg.mL-1 for the complex versus 0.015 mg.mL-1 for nimesulide), and 3600 in purified water (36.400 mg.mL-1 for the complex versus 0.01 mg.mL-1 for nimesulide). [less ▲] Detailed reference viewed: 23 (6 ULg) Synthesis and biological evaluation of new 3-aralkylamino-2-aryl-2H-1,2,4-pyridothiadiazine 1,1-dioxides as potential CCK receptor ligandsDe Tullio, Pascal ; Pirotte, Bernard ; et alin Journal of Pharmacy & Pharmacology (1997), 49 Detailed reference viewed: 7 (0 ULg) Study of the influence of g-cyclodextrin on the molsidomine photostabilityPiel, Géraldine ; ; Delattre, Luc et alPoster (1996, April) Detailed reference viewed: 9 (0 ULg) Preparation by spray drying of b and g-cyclodextrin inclusion complexes of a poorly soluble non steroidal anti-inflammatory drugPiel, Géraldine ; Pirotte, Bernard ; et alPoster (1996, February) Detailed reference viewed: 4 (0 ULg) Dibenzoazepine analogues : the electrophysiological properties of JL3, a potential atypical antidepressantLiégeois, Jean-François ; Scuvée-Moreau, Jacqueline ; Giesbers, Irène et alin European Journal of Pharmacology (1996), 310 Detailed reference viewed: 17 (2 ULg) Photostability studies of molsidomine-cyclodextrin complexesPiel, Géraldine ; ; Delattre, Luc et alPoster (1995, June) Detailed reference viewed: 13 (0 ULg) Les activateurs de canaux potassiques: étude structurale comparative du pinacidil, du diazoxide et du cromakalimDupont, Léon ; Pirotte, Bernard ; De Tullio, Pascal et alin Annales Pharmaceutiques Françaises (1995), 53(5), 201-8 A conformational analysis has been performed with SYBYL starting from the energy optimized (Tripos force field) X-ray conformation of (R,S)-pinacidil. The geometry of four selected low energy conformers ... [more ▼] A conformational analysis has been performed with SYBYL starting from the energy optimized (Tripos force field) X-ray conformation of (R,S)-pinacidil. The geometry of four selected low energy conformers has been reoptimized using the AM1 semiempirical Molecular Orbital method (MOPAC 5.0), and the total energy of the optimized conformers has been compared. In spite of an apparent structural dissimilarity, a good analogy has been found between the calculated isopotential map of diazoxide and that of at least one selected low energy conformer of pinacidil. It has been suggested that, unlike cromakalim, the low but observable activity of pinacidil on pancreatic B-cells could be explained by adoption for this compound of a conformation having a diazoxide-like stereoelectronical imprint which could assume a similar interaction on the same biological receptor. [less ▲] Detailed reference viewed: 16 (1 ULg) 3-Arylcarboxamidométhyl-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxydes en tant qu'antagonistes non peptidiques de la cholécystokinine: synthèse et évaluation pharmacologiquePirotte, Bernard ; De Tullio, Pascal ; et alin Journal de Pharmacie de Belgique (1995), 50 Detailed reference viewed: 4 (1 ULg) Synthèse de dérivés 3-aminoaralkyl-2-aryl-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxydes et leur évaluation en tant qu'antagonistes de la cholécystokinineDe Tullio, Pascal ; Pirotte, Bernard ; et alin Journal de Pharmacie de Belgique (1995), 50 Detailed reference viewed: 3 (1 ULg) 3-(Alkylamino)-4h-Pyrido[4,3-E]-1,2,4-Thiadiazine 1,1-Dioxides as Powerful Inhibitors of Insulin Release from Rat Pancreatic B-Cells: A New Class of Potassium Channel Openers?Pirotte, Bernard ; De Tullio, Pascal ; et alin Journal of Medicinal Chemistry (1993), 36(21), 3211-3 Detailed reference viewed: 28 (13 ULg) Synthèse, étude théorique et évaluation biologique de dérivés du 4-amino-4H-1,2,4-triazole analogues des antibiotiques b-lactamiquesPirotte, Bernard ; Dive, Georges ; et alin European Journal of Medicinal Chemistry (1992), 27(3), 193-205 Detailed reference viewed: 24 (7 ULg) New Alkoxypyridine-sulfonamides: synthesis, biological evaluation and physicochemical properties; Dive, Georges ; et alin Helvetica Chimica Acta (1991), 74(8), 1764-1772 Detailed reference viewed: 11 (3 ULg) New alkoxypyridine Sulfonamides: Synthesis, Biological Evaluation and Physicochemical PropertiesLiégeois, Jean-François ; Dive, Georges ; et alin Helvetica Chimica Acta (1991), 74 Detailed reference viewed: 11 (1 ULg) |
||